Cargando...
Peptide vaccine formulation controls the duration of antigen presentation and magnitude of tumor-specific CD8+ T cell response
Despite remarkable progresses in vaccinology, therapeutic cancer vaccines have not achieved their full potential. We previously showed that an excessively long duration of antigen presentation critically reduced the quantity and quality of vaccination-induced T cell responses and subsequent anti-tum...
Gardado en:
| Publicado en: | J Immunol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5940548/ https://ncbi.nlm.nih.gov/pubmed/29643190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1700467 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|